Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | SVP & Chief HR Officer | February 11, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,723 |
Ending reported balance
After 2026-02-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-11 · Grant · Acquired 1,200 · Balance 9,950 F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Row 2 · 2026-02-11 · Grant · Acquired 1,929 · Balance 11,879 F2: Represents the vesting of performance stock units (includes 31 dividend equivalent shares) for the 2023-2025 performance period. Row 3 · 2026-02-11 · Tax withholding · Disposed 991 · Balance 10,888 F3: 991 of the 1,929 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Row 4 · 2026-02-12 · Tax withholding · Disposed 165 · Balance 10,723 F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $178.68 · Expires 2036-02-11 | Direct | 4,400 |
Reported balance
After 2026-02-11 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-11 · Grant · Acquired 4,400 · Balance 4,400 F5: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 1,456 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,456 |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: Represents the vesting of performance stock units (includes 31 dividend equivalent shares) for the 2023-2025 performance period.
F3: 991 of the 1,929 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
F5: Options vest 20% Year 1, 40% Year 2, and 40% Year 3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2026 Filed Feb 13, 2026 22:59 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 165 | $177.49 | $29,285.85 |
DisclosureSEC source: 0001140361-26-005516 · form4.xml · nonDerivative · entry 4 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,723 F4 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:59 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 4,400 | $0.00 Strike: $178.68 | $0.00 |
DisclosureSEC source: 0001140361-26-005516 · form4.xml · derivative · entry 6 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,400 Underlying: Common Stock · 4,400 shares Expires 2036-02-11 F5 · derivative.exercise_date: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:59 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 991 | $178.68 | $177,071.88 |
DisclosureSEC source: 0001140361-26-005516 · form4.xml · nonDerivative · entry 3 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,888 F3 · shares: 991 of the 1,929 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:59 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005516 · form4.xml · nonDerivative · entry 2 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,879 F2 · shares: Represents the vesting of performance stock units (includes 31 dividend equivalent shares) for the 2023-2025 performance period. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:59 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005516 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,950 F1 · shares: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 21:28 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 373 | $173.16 | $64,588.68 |
DisclosureSEC source: 0001140361-26-004612 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,750 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/8/2023). Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:50 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,156 | $163.14 | $188,589.84 |
DisclosureSEC source: 0001140361-25-004916 · form4.xml · nonDerivative · entry 3 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,123 F3 · shares: 1,156 of the 2,207 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004916 · form4.xml · nonDerivative · entry 2 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,279 F2 · shares: Represents the vesting of performance stock units (includes 36 dividend equivalent shares) for the 2022-2024 performance period. Read SEC document |
| February 13, 2025 Filed Apr 11, 2025 22:43 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,156 | $163.14 | $188,589.84 |
DisclosureSEC source: 0001140361-25-013563 · form4.xml · nonDerivative · entry 3 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,123 F3 · shares: 1,156 of the 2,207 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 13, 2025 Filed Apr 11, 2025 22:43 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013563 · form4.xml · nonDerivative · entry 2 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,279 F2 · shares: Represents the vesting of performance stock units (includes 36 dividend equivalent shares) for the 2022-2024 performance period. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 4,200 | $0.00 Strike: $159.18 | $0.00 |
DisclosureSEC source: 0001140361-25-004916 · form4.xml · derivative · entry 5 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,200 Underlying: Common Stock · 4,200 shares Expires 2035-02-12 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004916 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,072 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 22:43 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 4,200 | $0.00 Strike: $159.18 | $0.00 |
DisclosureSEC source: 0001140361-25-013563 · form4.xml · derivative · entry 5 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,200 Underlying: Common Stock · 4,200 shares Expires 2035-02-12 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 22:43 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013563 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,072 F1 · shares: Ownership of restricted stock vests in Reporting Person ratably over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:18 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 334 | $159.39 | $53,236.26 |
DisclosureSEC source: 0001140361-25-004096 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,782 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/10/2022). Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:30 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Options (right to buy) · Derivative | 4,200 | $0.00 Strike: $85.40 | $0.00 |
DisclosureSEC source: 0001140361-24-012827 · form4.xml · derivative · entry 4 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,200 Underlying: Common Stock · 4,200 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Stock options that vested 20% on February 21, 2018, 40% on February 21, 2019, and 40% on February 21, 2020, and are exercisable. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:30 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 2,078 | $158.22 | $328,788.02 |
DisclosureSEC source: 0001140361-24-012827 · form4.xml · nonDerivative · entry 3 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,368 F4 · price: This transaction was executed in multiple sales ranging from $158.0000 to $158.7850 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:30 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 3,261 | $157.07 | $512,197.12 |
DisclosureSEC source: 0001140361-24-012827 · form4.xml · nonDerivative · entry 2 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,446 F3 · price: This transaction was executed in multiple sales ranging from $157.0000 to $157.1900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 20:30 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 4,200 | $85.40 | $358,680.00 |
DisclosureSEC source: 0001140361-24-012827 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. F2 · balance_after: Includes acquisition of shares (company match) under the Balchem Corporation 401(k) plan. Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 22:55 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 354 | $145.33 | $51,446.82 |
DisclosureSEC source: 0001140361-24-007550 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,418 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2,900 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007141 · form4.xml · derivative · entry 4 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,900 Underlying: Common Stock · 2,900 shares Expires 2034-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,244 | $143.43 | $178,426.92 |
DisclosureSEC source: 0001140361-24-007141 · form4.xml · nonDerivative · entry 3 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,772 F4 · shares: 1,244 of the 2,104 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007141 · form4.xml · nonDerivative · entry 2 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,016 F3 · shares: Represents the vesting of performance stock units (includes 33 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:01 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007141 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,912 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:16 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 297 | $135.67 | $40,293.99 |
DisclosureSEC source: 0001140361-23-007250 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,879 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2,300 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006116 · form4.xml · derivative · entry 4 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Underlying: Common Stock · 2,300 shares Expires 2033-02-08 F5 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,060 | $138.09 | $146,375.40 |
DisclosureSEC source: 0001140361-23-006116 · form4.xml · nonDerivative · entry 3 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,176 F4 · shares: 1,060 of the 1,989 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006116 · form4.xml · nonDerivative · entry 2 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,236 F3 · shares: Represents the vesting of performance stock units (includes 30 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 660 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006116 · form4.xml · nonDerivative · entry 1 Tignor Michael Brent · CIK 0001908271 · SVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,247 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.